{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:19:03Z","timestamp":1781716743827,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":167,"publisher":"Springer US","isbn-type":[{"value":"9781071622643","type":"print"},{"value":"9781071622650","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2265-0_13","type":"book-chapter","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T16:04:57Z","timestamp":1650297897000},"page":"247-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Systems Biology to Address Unmet Medical Needs in Neurological Disorders"],"prefix":"10.1007","author":[{"given":"Masha G.","family":"Savelieff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Noureldein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2016 Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x","DOI":"10.1016\/s1474-4422(18)30499-x"},{"issue":"2","key":"13_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377(2):162\u2013172. https:\/\/doi.org\/10.1056\/NEJMra1603471","journal-title":"N Engl J Med"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https:\/\/doi.org\/10.1038\/nrdp.2017.71","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"13_CR4","doi-asserted-by":"publisher","first-page":"e802","DOI":"10.1212\/WNL.0000000000008869","volume":"94","author":"A Chi\u00f2","year":"2020","unstructured":"Chi\u00f2 A, Moglia C, Canosa A et al (2020) ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology 94(8):e802\u2013e810. https:\/\/doi.org\/10.1212\/WNL.0000000000008869","journal-title":"Neurology"},{"issue":"1","key":"13_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/s1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia R, Chio A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17(1):94\u2013102. https:\/\/doi.org\/10.1016\/s1474-4422(17)30401-5","journal-title":"Lancet Neurol"},{"issue":"9","key":"13_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng.3622","volume":"48","author":"W van Rheenen","year":"2016","unstructured":"van Rheenen W, Shatunov A, Dekker AM et al (2016) Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet 48(9):1043\u20131048. https:\/\/doi.org\/10.1038\/ng.3622","journal-title":"Nat Genet"},{"issue":"4","key":"13_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.25431","volume":"85","author":"S Bandres-Ciga","year":"2019","unstructured":"Bandres-Ciga S, Noyce AJ, Hemani G et al (2019) Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol 85(4):470\u2013481. https:\/\/doi.org\/10.1002\/ana.25431","journal-title":"Ann Neurol"},{"issue":"8","key":"13_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/jnnp-2018-319785","volume":"90","author":"SA Goutman","year":"2019","unstructured":"Goutman SA, Boss J, Patterson A et al (2019) High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 90(8):907\u2013912. https:\/\/doi.org\/10.1136\/jnnp-2018-319785","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"13_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1001\/jamaneurol.2016.0594","volume":"73","author":"FC Su","year":"2016","unstructured":"Su FC, Goutman SA, Chernyak S et al (2016) Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol 73(7):803\u2013811. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0594","journal-title":"JAMA Neurol"},{"issue":"6","key":"13_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101186","volume":"9","author":"Y Yu","year":"2014","unstructured":"Yu Y, Su FC, Callaghan BC et al (2014) Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan. PLoS One 9(6):e101186. https:\/\/doi.org\/10.1371\/journal.pone.0101186","journal-title":"PLoS One"},{"issue":"11","key":"13_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","volume":"9","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9(11):617\u2013628. https:\/\/doi.org\/10.1038\/nrneurol.2013.203","journal-title":"Nat Rev Neurol"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2015.02.017","volume":"77","author":"BJ Murdock","year":"2015","unstructured":"Murdock BJ, Bender DE, Segal BM et al (2015) The dual roles of immunity in ALS: injury overrides protection. Neurobiol Dis 77:1\u201312. https:\/\/doi.org\/10.1016\/j.nbd.2015.02.017","journal-title":"Neurobiol Dis"},{"issue":"4","key":"13_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000242","volume":"3","author":"BJ Murdock","year":"2016","unstructured":"Murdock BJ, Bender DE, Kashlan SR et al (2016) Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 3(4):e242. https:\/\/doi.org\/10.1212\/nxi.0000000000000242","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"13_CR14","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","volume":"74","author":"BJ Murdock","year":"2017","unstructured":"Murdock BJ, Zhou T, Kashlan SR et al (2017) Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol 74(12):1446\u20131454. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2255","journal-title":"JAMA Neurol"},{"issue":"2","key":"13_CR15","doi-asserted-by":"publisher","first-page":"e953","DOI":"10.1212\/nxi.0000000000000953","volume":"8","author":"BJ Murdock","year":"2021","unstructured":"Murdock BJ, Goutman SA, Boss J et al (2021) Amyotrophic lateral sclerosis survival associates with neutrophils in a sex-specific manner. Neurol Neuroimmunol Neuroinflamm 8(2):e953. https:\/\/doi.org\/10.1212\/nxi.0000000000000953","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"13_CR16","doi-asserted-by":"publisher","first-page":"e147129","DOI":"10.1172\/jci.insight.147129","volume":"6","author":"BJ Murdock","year":"2021","unstructured":"Murdock BJ, Famie JP, Piecuch CE et al (2021) Natural killer cells associate with amyotrophic lateral sclerosis in a sex- and age-dependent manner. JCI Insight 6(11):e147129. https:\/\/doi.org\/10.1172\/jci.insight.147129","journal-title":"JCI Insight"},{"issue":"5","key":"13_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/wco.0000000000000599","volume":"31","author":"JR Thonhoff","year":"2018","unstructured":"Thonhoff JR, Simpson EP, Appel SH (2018) Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr Opin Neurol 31(5):635\u2013639. https:\/\/doi.org\/10.1097\/wco.0000000000000599","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"13_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","volume":"11","author":"X Paez-Colasante","year":"2015","unstructured":"Paez-Colasante X, Figueroa-Romero C, Sakowski SA et al (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol 11(5):266\u2013279. https:\/\/doi.org\/10.1038\/nrneurol.2015.57","journal-title":"Nat Rev Neurol"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fncel.2020.00117","volume":"14","author":"X Paez-Colasante","year":"2020","unstructured":"Paez-Colasante X, Figueroa-Romero C, Rumora AE et al (2020) Cytoplasmic TDP43 binds microRNAs: new disease targets in amyotrophic lateral sclerosis. Front Cell Neurosci 14:117. https:\/\/doi.org\/10.3389\/fncel.2020.00117","journal-title":"Front Cell Neurosci"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2015.12.008","volume":"71","author":"C Figueroa-Romero","year":"2016","unstructured":"Figueroa-Romero C, Hur J, Lunn JS et al (2016) Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol Cell Neurosci 71:34\u201345. https:\/\/doi.org\/10.1016\/j.mcn.2015.12.008","journal-title":"Mol Cell Neurosci"},{"issue":"Suppl 1","key":"13_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/21678421.2013.778571","volume":"14","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi A, Kwak S, Mehler M et al (2013) Genetic and epigenetic studies of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14(Suppl 1):44\u201352. https:\/\/doi.org\/10.3109\/21678421.2013.778571","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"13_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12031-018-1204-1","volume":"66","author":"E Dardiotis","year":"2018","unstructured":"Dardiotis E, Aloizou AM, Siokas V et al (2018) The role of microRNAs in patients with amyotrophic lateral sclerosis. J Mol Neurosci 66(4):617\u2013628. https:\/\/doi.org\/10.1007\/s12031-018-1204-1","journal-title":"J Mol Neurosci"},{"issue":"6435","key":"13_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aav9776","volume":"364","author":"S Maniatis","year":"2019","unstructured":"Maniatis S, \u00c4ij\u00f6 T, Vickovic S et al (2019) Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364(6435):89\u201393. https:\/\/doi.org\/10.1126\/science.aav9776","journal-title":"Science"},{"issue":"1","key":"13_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15(1):45. https:\/\/doi.org\/10.1186\/s13024-020-00397-1","journal-title":"Mol Neurodegener"},{"issue":"12","key":"13_CR25","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1136\/jnnp-2020-323611","volume":"91","author":"SA Goutman","year":"2020","unstructured":"Goutman SA, Boss J, Guo K et al (2020) Untargeted metabolomics yields insight into ALS disease mechanisms. J Neurol Neurosurg Psychiatry 91(12):1329\u20131338. https:\/\/doi.org\/10.1136\/jnnp-2020-323611","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"13_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/ene.12956","volume":"23","author":"H Blasco","year":"2016","unstructured":"Blasco H, Patin F, Madji Hounoum B et al (2016) Metabolomics in amyotrophic lateral sclerosis: how far can it take us? Eur J Neurol 23(3):447\u2013454. https:\/\/doi.org\/10.1111\/ene.12956","journal-title":"Eur J Neurol"},{"issue":"9","key":"13_CR27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/14737175.2020.1788389","volume":"20","author":"H Blasco","year":"2020","unstructured":"Blasco H, Lanznaster D, Veyrat-Durebex C et al (2020) Understanding and managing metabolic dysfunction in amyotrophic lateral sclerosis. Expert Rev Neurother 20(9):907\u2013919. https:\/\/doi.org\/10.1080\/14737175.2020.1788389","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"13_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/1673-5374.244782","volume":"14","author":"MJ Fogarty","year":"2019","unstructured":"Fogarty MJ (2019) Amyotrophic lateral sclerosis as a synaptopathy. Neural Regen Res 14(2):189\u2013192. https:\/\/doi.org\/10.4103\/1673-5374.244782","journal-title":"Neural Regen Res"},{"key":"13_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933. https:\/\/doi.org\/10.1016\/j.neulet.2017.06.052","journal-title":"Neurosci Lett"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.freeradbiomed.2013.06.029","volume":"65","author":"E D\u2019Amico","year":"2013","unstructured":"D\u2019Amico E, Factor-Litvak P, Santella RM et al (2013) Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med 65:509\u2013527. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.06.029","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"13_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R et al (2019) Diabetic neuropathy. Nat Rev Dis Primers 5(1):41. https:\/\/doi.org\/10.1038\/s41572-019-0092-1","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"13_CR32","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/brain\/awab079","volume":"144","author":"TS Jensen","year":"2021","unstructured":"Jensen TS, Karlsson P, Gylfadottir SS et al (2021) Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain 144(6):1632\u20131645. https:\/\/doi.org\/10.1093\/brain\/awab079","journal-title":"Brain"},{"issue":"9427","key":"13_CR33","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/s0140-6736(04)16508-2","volume":"363","author":"JD England","year":"2004","unstructured":"England JD, Asbury AK (2004) Peripheral neuropathy. Lancet 363(9427):2151\u20132161. https:\/\/doi.org\/10.1016\/s0140-6736(04)16508-2","journal-title":"Lancet"},{"key":"13_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"issue":"17","key":"13_CR35","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17):2735\u20132752. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"issue":"10113","key":"13_CR36","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/s0140-6736(17)32129-3","volume":"390","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2017) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults (2017). Lancet 390(10113):2627\u20132642. https:\/\/doi.org\/10.1016\/s0140-6736(17)32129-3","journal-title":"Lancet"},{"issue":"2","key":"13_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG (2018) The global epidemic of the metabolic syndrome. Curr Hypertens Rep 20(2):12. https:\/\/doi.org\/10.1007\/s11906-018-0812-z","journal-title":"Curr Hypertens Rep"},{"issue":"7","key":"13_CR38","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.mayocp.2020.03.025","volume":"95","author":"BC Callaghan","year":"2020","unstructured":"Callaghan BC, Reynolds E, Banerjee M et al (2020) Central obesity is associated with neuropathy in the severely obese. Mayo Clin Proc 95(7):1342\u20131353. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.025","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"13_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc16-0081","volume":"39","author":"BC Callaghan","year":"2016","unstructured":"Callaghan BC, Xia R, Banerjee M et al (2016) Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status. Diabetes Care 39(5):801\u2013807. https:\/\/doi.org\/10.2337\/dc16-0081","journal-title":"Diabetes Care"},{"issue":"12","key":"13_CR40","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/jamaneurol.2016.3745","volume":"73","author":"BC Callaghan","year":"2016","unstructured":"Callaghan BC, Xia R, Reynolds E et al (2016) Association between metabolic syndrome components and polyneuropathy in an obese population. JAMA Neurol 73(12):1468\u20131476. https:\/\/doi.org\/10.1001\/jamaneurol.2016.3745","journal-title":"JAMA Neurol"},{"issue":"9","key":"13_CR41","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2337\/dc17-0179","volume":"40","author":"M Jaiswal","year":"2017","unstructured":"Jaiswal M, Divers J, Dabelea D et al (2017) Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study. Diabetes Care 40(9):1226\u20131232. https:\/\/doi.org\/10.2337\/dc17-0179","journal-title":"Diabetes Care"},{"issue":"4","key":"13_CR42","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.2337\/dc16-0082","volume":"39","author":"M Jaiswal","year":"2016","unstructured":"Jaiswal M, Fufaa GD, Martin CL et al (2016) Burden of diabetic peripheral neuropathy in Pima Indians with type 2 diabetes. Diabetes Care 39(4):e63\u2013e64. https:\/\/doi.org\/10.2337\/dc16-0082","journal-title":"Diabetes Care"},{"issue":"3","key":"13_CR43","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2337\/dc10-0878","volume":"34","author":"BC Callaghan","year":"2011","unstructured":"Callaghan BC, Feldman E, Liu J et al (2011) Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care 34(3):635\u2013640. https:\/\/doi.org\/10.2337\/dc10-0878","journal-title":"Diabetes Care"},{"issue":"5","key":"13_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jdiacomp.2013.04.003","volume":"27","author":"AG Smith","year":"2013","unstructured":"Smith AG, Singleton JR (2013) Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complicat 27(5):436\u2013442. https:\/\/doi.org\/10.1016\/j.jdiacomp.2013.04.003","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"13_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/acn3.531","volume":"5","author":"BC Callaghan","year":"2018","unstructured":"Callaghan BC, Gao L, Li Y et al (2018) Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol 5(4):397\u2013405. https:\/\/doi.org\/10.1002\/acn3.531","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"13_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061053","volume":"8","author":"B Lu","year":"2013","unstructured":"Lu B, Hu J, Wen J et al (2013) Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes\u2014ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). PLoS One 8(4):e61053. https:\/\/doi.org\/10.1371\/journal.pone.0061053","journal-title":"PLoS One"},{"key":"13_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13098-015-0010-y","volume":"7","author":"L Han","year":"2015","unstructured":"Han L, Ji L, Chang J et al (2015) Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome. Diabetol Metab Syndr 7:14. https:\/\/doi.org\/10.1186\/s13098-015-0010-y","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"13_CR48","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2337\/dc17-2062","volume":"41","author":"ST Andersen","year":"2018","unstructured":"Andersen ST, Witte DR, Dalsgaard EM et al (2018) Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark. Diabetes Care 41(5):1068\u20131075. https:\/\/doi.org\/10.2337\/dc17-2062","journal-title":"Diabetes Care"},{"issue":"6","key":"13_CR49","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2337\/dc19-2277","volume":"43","author":"DH Christensen","year":"2020","unstructured":"Christensen DH, Knudsen ST, Gylfadottir SS et al (2020) Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: a nationwide study of 5,249 patients in the Danish Centre for Strategic Research in type 2 diabetes (DD2) cohort. Diabetes Care 43(6):1266\u20131275. https:\/\/doi.org\/10.2337\/dc19-2277","journal-title":"Diabetes Care"},{"issue":"2","key":"13_CR50","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2337\/dc18-1842","volume":"42","author":"S Schlesinger","year":"2019","unstructured":"Schlesinger S, Herder C, Kannenberg JM et al (2019) General and abdominal obesity and incident distal sensorimotor polyneuropathy: insights into inflammatory biomarkers as potential mediators in the KORA F4\/FF4 cohort. Diabetes Care 42(2):240\u2013247. https:\/\/doi.org\/10.2337\/dc18-1842","journal-title":"Diabetes Care"},{"issue":"3","key":"13_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2337\/dc07-1796","volume":"31","author":"D Ziegler","year":"2008","unstructured":"Ziegler D, Rathmann W, Dickhaus T et al (2008) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3. Diabetes Care 31(3):464\u2013469. https:\/\/doi.org\/10.2337\/dc07-1796","journal-title":"Diabetes Care"},{"issue":"2","key":"13_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jns.12211","volume":"22","author":"R Hanewinckel","year":"2017","unstructured":"Hanewinckel R, Ikram MA, Franco OH et al (2017) High body mass and kidney dysfunction relate to worse nerve function, even in adults without neuropathy. J Peripher Nerv Syst 22(2):112\u2013120. https:\/\/doi.org\/10.1111\/jns.12211","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"13_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/med.0000000000000533","volume":"27","author":"MG Savelieff","year":"2020","unstructured":"Savelieff MG, Callaghan BC, Feldman EL (2020) The emerging role of dyslipidemia in diabetic microvascular complications. Curr Opin Endocrinol Diabetes Obes 27(2):115\u2013123. https:\/\/doi.org\/10.1097\/med.0000000000000533","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"13_CR54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MED.0000000000000320","volume":"24","author":"A Grisold","year":"2017","unstructured":"Grisold A, Callaghan BC, Feldman EL (2017) Mediators of diabetic neuropathy: is hyperglycemia the only culprit? Curr Opin Endocrinol Diabetes Obes 24(2):103\u2013111. https:\/\/doi.org\/10.1097\/MED.0000000000000320","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"13_CR55","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/jdi.12650","volume":"8","author":"AM Stino","year":"2017","unstructured":"Stino AM, Smith AG (2017) Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig 8(5):646\u2013655. https:\/\/doi.org\/10.1111\/jdi.12650","journal-title":"J Diabetes Investig"},{"issue":"3","key":"13_CR56","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2337\/dc19-1642","volume":"43","author":"BC Callaghan","year":"2020","unstructured":"Callaghan BC, Reynolds EL, Banerjee M et al (2020) The prevalence and determinants of cognitive deficits and traditional diabetic complications in the severely obese. Diabetes Care 43(3):683\u2013690. https:\/\/doi.org\/10.2337\/dc19-1642","journal-title":"Diabetes Care"},{"issue":"6","key":"13_CR57","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman EL, Nave KA, Jensen TS et al (2017) New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 93(6):1296\u20131313. https:\/\/doi.org\/10.1016\/j.neuron.2017.02.005","journal-title":"Neuron"},{"key":"13_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.irn.2019.05.002","volume":"145","author":"AE Rumora","year":"2019","unstructured":"Rumora AE, Savelieff MG, Sakowski SA et al (2019) Disorders of mitochondrial dynamics in peripheral neuropathy: clues from hereditary neuropathy and diabetes. Int Rev Neurobiol 145:127\u2013176. https:\/\/doi.org\/10.1016\/bs.irn.2019.05.002","journal-title":"Int Rev Neurobiol"},{"key":"13_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nbd.2012.03.016","volume":"51","author":"SK Chowdhury","year":"2013","unstructured":"Chowdhury SK, Smith DR, Fernyhough P (2013) The role of aberrant mitochondrial bioenergetics in diabetic neuropathy. Neurobiol Dis 51:56\u201365. https:\/\/doi.org\/10.1016\/j.nbd.2012.03.016","journal-title":"Neurobiol Dis"},{"issue":"4","key":"13_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11154-008-9104-2","volume":"9","author":"C Figueroa-Romero","year":"2008","unstructured":"Figueroa-Romero C, Sadidi M, Feldman EL (2008) Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 9(4):301\u2013314. https:\/\/doi.org\/10.1007\/s11154-008-9104-2","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"13_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","volume":"16","author":"R Pop-Busui","year":"2016","unstructured":"Pop-Busui R, Ang L, Holmes C et al (2016) Inflammation as a therapeutic target for diabetic neuropathies. Curr Diab Rep 16(3):29. https:\/\/doi.org\/10.1007\/s11892-016-0727-5","journal-title":"Curr Diab Rep"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fncel.2020.00148","volume":"14","author":"F Bou\u00e7anova","year":"2020","unstructured":"Bou\u00e7anova F, Chrast R (2020) Metabolic interaction between Schwann cells and axons under physiological and disease conditions. Front Cell Neurosci 14:148. https:\/\/doi.org\/10.3389\/fncel.2020.00148","journal-title":"Front Cell Neurosci"},{"key":"13_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.589582","volume":"14","author":"MK Jha","year":"2020","unstructured":"Jha MK, Morrison BM (2020) Lactate transporters mediate glia-neuron metabolic crosstalk in homeostasis and disease. Front Cell Neurosci 14:589582. https:\/\/doi.org\/10.3389\/fncel.2020.589582","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"13_CR64","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ilar\/ilt052","volume":"54","author":"PD O\u2019Brien","year":"2014","unstructured":"O\u2019Brien PD, Sakowski SA, Feldman EL (2014) Mouse models of diabetic neuropathy. ILAR J 54(3):259\u2013272. https:\/\/doi.org\/10.1093\/ilar\/ilt052","journal-title":"ILAR J"},{"issue":"Pt 11","key":"13_CR65","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1093\/brain\/awr228","volume":"134","author":"J Hur","year":"2011","unstructured":"Hur J, Sullivan KA, Pande M et al (2011) The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain 134(Pt 11):3222\u20133235. https:\/\/doi.org\/10.1093\/brain\/awr228","journal-title":"Brain"},{"issue":"7","key":"13_CR66","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2337\/db10-1541","volume":"60","author":"M Pande","year":"2011","unstructured":"Pande M, Hur J, Hong Y et al (2011) Transcriptional profiling of diabetic neuropathy in the BKS db\/db mouse: a model of type 2 diabetes. Diabetes 60(7):1981\u20131989. https:\/\/doi.org\/10.2337\/db10-1541","journal-title":"Diabetes"},{"issue":"12","key":"13_CR67","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.2337\/dc12-2530","volume":"36","author":"J Hur","year":"2013","unstructured":"Hur J, Sullivan KA, Callaghan BC et al (2013) Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy. Diabetes Care 36(12):4043\u20134049. https:\/\/doi.org\/10.2337\/dc12-2530","journal-title":"Diabetes Care"},{"key":"13_CR68","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.nbd.2014.10.015","volume":"73","author":"PD O\u2019Brien","year":"2015","unstructured":"O\u2019Brien PD, Hur J, Hayes JM et al (2015) BTBR ob\/ob mice as a novel diabetic neuropathy model: neurological characterization and gene expression analyses. Neurobiol Dis 73:348\u2013355. https:\/\/doi.org\/10.1016\/j.nbd.2014.10.015","journal-title":"Neurobiol Dis"},{"key":"13_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.112967","volume":"320","author":"S Elzinga","year":"2019","unstructured":"Elzinga S, Murdock BJ, Guo K et al (2019) Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? Exp Neurol 320:112967. https:\/\/doi.org\/10.1016\/j.expneurol.2019.112967","journal-title":"Exp Neurol"},{"key":"13_CR70","doi-asserted-by":"publisher","unstructured":"Callaghan BC, Little AA, Feldman EL, et al (2012) Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev (6):CD007543. https:\/\/doi.org\/10.1002\/14651858.CD007543.pub2","DOI":"10.1002\/14651858.CD007543.pub2"},{"issue":"6","key":"13_CR71","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00125-016-3913-8","volume":"59","author":"J Hur","year":"2016","unstructured":"Hur J, O\u2019Brien PD, Nair V et al (2016) Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns. Diabetologia 59(6):1297\u20131306. https:\/\/doi.org\/10.1007\/s00125-016-3913-8","journal-title":"Diabetologia"},{"issue":"1","key":"13_CR72","doi-asserted-by":"publisher","first-page":"17678","DOI":"10.1038\/s41598-018-36098-5","volume":"8","author":"BA McGregor","year":"2018","unstructured":"McGregor BA, Eid S, Rumora AE et al (2018) Conserved transcriptional signatures in human and murine diabetic peripheral neuropathy. Sci Rep 8(1):17678. https:\/\/doi.org\/10.1038\/s41598-018-36098-5","journal-title":"Sci Rep"},{"issue":"12","key":"13_CR73","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11892-019-1270-y","volume":"19","author":"HE Lebovitz","year":"2019","unstructured":"Lebovitz HE (2019) Thiazolidinediones: the forgotten diabetes medications. Curr Diab Rep 19(12):151. https:\/\/doi.org\/10.1007\/s11892-019-1270-y","journal-title":"Curr Diab Rep"},{"issue":"10","key":"13_CR74","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1210\/en.2008-0869","volume":"149","author":"TD Wiggin","year":"2008","unstructured":"Wiggin TD, Kretzler M, Pennathur S et al (2008) Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA\/2J mice. Endocrinology 149(10):4928\u20134937. https:\/\/doi.org\/10.1210\/en.2008-0869","journal-title":"Endocrinology"},{"issue":"9","key":"13_CR75","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.2337\/db15-0133","volume":"64","author":"J Hur","year":"2015","unstructured":"Hur J, Dauch JR, Hinder LM et al (2015) The metabolic syndrome and microvascular complications in a murine model of type 2 diabetes. Diabetes 64(9):3294\u20133304. https:\/\/doi.org\/10.2337\/db15-0133","journal-title":"Diabetes"},{"issue":"9","key":"13_CR76","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1111\/jcmm.13136","volume":"21","author":"LM Hinder","year":"2017","unstructured":"Hinder LM, Park M, Rumora AE et al (2017) Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease. J Cell Mol Med 21(9):2140\u20132152. https:\/\/doi.org\/10.1111\/jcmm.13136","journal-title":"J Cell Mol Med"},{"issue":"1","key":"13_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12918-018-0674-7","volume":"13","author":"G de Anda-Jauregui","year":"2019","unstructured":"de Anda-Jauregui G, Guo K, McGregor BA et al (2019) Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone. BMC Syst Biol 13(1):1. https:\/\/doi.org\/10.1186\/s12918-018-0674-7","journal-title":"BMC Syst Biol"},{"issue":"15","key":"13_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86976","volume":"1","author":"KM Sas","year":"2016","unstructured":"Sas KM, Kayampilly P, Byun J et al (2016) Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight 1(15):e86976. https:\/\/doi.org\/10.1172\/jci.insight.86976","journal-title":"JCI Insight"},{"issue":"5795","key":"13_CR79","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D et al (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929\u20131935. https:\/\/doi.org\/10.1126\/science.1132939","journal-title":"Science"},{"key":"13_CR80","doi-asserted-by":"publisher","unstructured":"O\u2019Brien PD, Guo K, Eid SA et al (2020) Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes. Dis Model Mech 13(2). https:\/\/doi.org\/10.1242\/dmm.042101","DOI":"10.1242\/dmm.042101"},{"issue":"9","key":"13_CR81","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/s2468-1253(20)30186-2","volume":"5","author":"R Loomba","year":"2020","unstructured":"Loomba R, Morgan E, Watts L et al (2020) Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol 5(9):829\u2013838. https:\/\/doi.org\/10.1016\/s2468-1253(20)30186-2","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"13_CR82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-020-00913-6","volume":"12","author":"K Guo","year":"2020","unstructured":"Guo K, Eid SA, Elzinga SE et al (2020) Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy. Clin Epigenetics 12(1):123. https:\/\/doi.org\/10.1186\/s13148-020-00913-6","journal-title":"Clin Epigenetics"},{"key":"13_CR83","doi-asserted-by":"publisher","first-page":"21.29.21","DOI":"10.1002\/0471142727.mb2129s109","volume":"109","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro JD, Wu B, Chang HY et al (2015) ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr Protoc Mol Biol 109:21.29.21\u201321.29.29. https:\/\/doi.org\/10.1002\/0471142727.mb2129s109","journal-title":"Curr Protoc Mol Biol"},{"issue":"7","key":"13_CR84","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","volume":"52","author":"M Vujkovic","year":"2020","unstructured":"Vujkovic M, Keaton JM, Lynch JA et al (2020) Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet 52(7):680\u2013691. https:\/\/doi.org\/10.1038\/s41588-020-0637-y","journal-title":"Nat Genet"},{"issue":"8","key":"13_CR85","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2337\/db19-0109","volume":"68","author":"Y Tang","year":"2019","unstructured":"Tang Y, Lenzini PA, Pop-Busui R et al (2019) A genetic locus on chromosome 2q24 predicting peripheral neuropathy risk in type 2 diabetes: results from the ACCORD and BARI 2D studies. Diabetes 68(8):1649\u20131662. https:\/\/doi.org\/10.2337\/db19-0109","journal-title":"Diabetes"},{"issue":"7418","key":"13_CR86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55\u201360. https:\/\/doi.org\/10.1038\/nature11450","journal-title":"Nature"},{"issue":"12","key":"13_CR87","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/nu12123719","volume":"12","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Neculae E et al (2020) Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM). Nutrients 12(12):3719. https:\/\/doi.org\/10.3390\/nu12123719","journal-title":"Nutrients"},{"issue":"42","key":"13_CR88","doi-asserted-by":"publisher","first-page":"26482","DOI":"10.1073\/pnas.2006065117","volume":"117","author":"RR Bonomo","year":"2020","unstructured":"Bonomo RR, Cook TM, Gavini CK et al (2020) Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice. Proc Natl Acad Sci U S A 117(42):26482\u201326493. https:\/\/doi.org\/10.1073\/pnas.2006065117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110147","volume":"127","author":"J Xie","year":"2020","unstructured":"Xie J, Song W, Liang X et al (2020) Protective effect of quercetin on streptozotocin-induced diabetic peripheral neuropathy rats through modulating gut microbiota and reactive oxygen species level. Biomed Pharmacother 127:110147. https:\/\/doi.org\/10.1016\/j.biopha.2020.110147","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"13_CR90","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13838","volume":"32","author":"Y Nyavor","year":"2020","unstructured":"Nyavor Y, Brands CR, May G et al (2020) High-fat diet-induced alterations to gut microbiota and gut-derived lipoteichoic acid contributes to the development of enteric neuropathy. Neurogastroenterol Motil 32(7):e13838. https:\/\/doi.org\/10.1111\/nmo.13838","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"13_CR91","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.2020.0700","volume":"324","author":"BC Callaghan","year":"2020","unstructured":"Callaghan BC, Price RS, Feldman EL (2020) Distal symmetric polyneuropathy in 2020. JAMA 324(1):90\u201391. https:\/\/doi.org\/10.1001\/jama.2020.0700","journal-title":"JAMA"},{"key":"13_CR92","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/bs.apha.2018.04.005","volume":"83","author":"S Srinivasan","year":"2018","unstructured":"Srinivasan S, Yee SW, Giacomini KM (2018) Pharmacogenetics of antidiabetic drugs. Adv Pharmacol 83:361\u2013389. https:\/\/doi.org\/10.1016\/bs.apha.2018.04.005","journal-title":"Adv Pharmacol"},{"issue":"11","key":"13_CR93","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/s2213-8587(18)30052-4","volume":"6","author":"AL Gloyn","year":"2018","unstructured":"Gloyn AL, Drucker DJ (2018) Precision medicine in the management of type 2 diabetes. Lancet Diabetes Endocrinol 6(11):891\u2013900. https:\/\/doi.org\/10.1016\/s2213-8587(18)30052-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"13_CR94","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.2337\/dc16-0738","volume":"39","author":"JS Floyd","year":"2016","unstructured":"Floyd JS, Psaty BM (2016) The application of genomics in diabetes: barriers to discovery and implementation. Diabetes Care 39(11):1858\u20131869. https:\/\/doi.org\/10.2337\/dc16-0738","journal-title":"Diabetes Care"},{"issue":"5","key":"13_CR95","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/pgs-2016-0185","volume":"18","author":"M Chaudhry","year":"2017","unstructured":"Chaudhry M, Alessandrini M, Rademan J et al (2017) Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study. Pharmacogenomics 18(5):433\u2013443. https:\/\/doi.org\/10.2217\/pgs-2016-0185","journal-title":"Pharmacogenomics"},{"issue":"3","key":"13_CR96","doi-asserted-by":"publisher","first-page":"ENEURO.0066-20.","DOI":"10.1523\/eneuro.0066-20.2020","volume":"7","author":"JS Toma","year":"2020","unstructured":"Toma JS, Karamboulas K, Carr MJ et al (2020) Peripheral nerve single-cell analysis identifies mesenchymal ligands that promote axonal growth. eNeuro 7(3):ENEURO.0066-20.2020. https:\/\/doi.org\/10.1523\/eneuro.0066-20.2020","journal-title":"eNeuro"},{"issue":"17","key":"13_CR97","doi-asserted-by":"publisher","first-page":"9466","DOI":"10.1073\/pnas.1912139117","volume":"117","author":"J Wolbert","year":"2020","unstructured":"Wolbert J, Li X, Heming M et al (2020) Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity. Proc Natl Acad Sci U S A 117(17):9466\u20139476. https:\/\/doi.org\/10.1073\/pnas.1912139117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"13_CR98","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9(7):a028035. https:\/\/doi.org\/10.1101\/cshperspect.a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"13_CR99","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/ijms20030719","volume":"20","author":"M Van Bulck","year":"2019","unstructured":"Van Bulck M, Sierra-Magro A, Alarcon-Gil J et al (2019) Novel approaches for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 20(3):719. https:\/\/doi.org\/10.3390\/ijms20030719","journal-title":"Int J Mol Sci"},{"issue":"2","key":"13_CR100","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","volume":"119","author":"MG Savelieff","year":"2019","unstructured":"Savelieff MG, Nam G, Kang J et al (2019) Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade. Chem Rev 119(2):1221\u20131322. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00138","journal-title":"Chem Rev"},{"issue":"1","key":"13_CR101","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","volume":"16","author":"V Sudhakar","year":"2019","unstructured":"Sudhakar V, Richardson RM (2019) Gene therapy for neurodegenerative diseases. Neurotherapeutics 16(1):166\u2013175. https:\/\/doi.org\/10.1007\/s13311-018-00694-0","journal-title":"Neurotherapeutics"},{"key":"13_CR102","doi-asserted-by":"publisher","unstructured":"2020 Alzheimer\u2019s disease facts and figures (2020). Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12068","DOI":"10.1002\/alz.12068"},{"key":"13_CR103","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K et al (2015) Alzheimer\u2019s disease. Nat Rev Dis Primers 1:15056. https:\/\/doi.org\/10.1038\/nrdp.2015.56","journal-title":"Nat Rev Dis Primers"},{"key":"13_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104976","volume":"143","author":"SM Neuner","year":"2020","unstructured":"Neuner SM, Tcw J, Goate AM (2020) Genetic architecture of Alzheimer\u2019s disease. Neurobiol Dis 143:104976. https:\/\/doi.org\/10.1016\/j.nbd.2020.104976","journal-title":"Neurobiol Dis"},{"issue":"3","key":"13_CR105","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3233\/jad181028","volume":"67","author":"A Serrano-Pozo","year":"2019","unstructured":"Serrano-Pozo A, Growdon JH (2019) Is Alzheimer\u2019s disease risk modifiable? J Alzheimers Dis 67(3):795\u2013819. https:\/\/doi.org\/10.3233\/jad181028","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"13_CR106","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/jnnp-2015-310548","volume":"86","author":"W Xu","year":"2015","unstructured":"Xu W, Tan L, Wang HF et al (2015) Meta-analysis of modifiable risk factors for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 86(12):1299\u20131306. https:\/\/doi.org\/10.1136\/jnnp-2015-310548","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"13_CR107","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jalz.2019.06.3914","volume":"15","author":"CE Finch","year":"2019","unstructured":"Finch CE, Kulminski AM (2019) The Alzheimer\u2019s disease exposome. Alzheimers Dement 15(9):1123\u20131132. https:\/\/doi.org\/10.1016\/j.jalz.2019.06.3914","journal-title":"Alzheimers Dement"},{"key":"13_CR108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neubiorev.2019.06.018","volume":"103","author":"AR Dunn","year":"2019","unstructured":"Dunn AR, O\u2019Connell KMS, Kaczorowski CC (2019) Gene-by-environment interactions in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neurosci Biobehav Rev 103:73\u201380. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.06.018","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"13_CR109","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1039\/c6cs00731g","volume":"46","author":"SJ Lee","year":"2017","unstructured":"Lee SJ, Nam E, Lee HJ et al (2017) Towards an understanding of amyloid-beta oligomers: characterization, toxicity mechanisms, and inhibitors. Chem Soc Rev 46(2):310\u2013323. https:\/\/doi.org\/10.1039\/c6cs00731g","journal-title":"Chem Soc Rev"},{"issue":"5","key":"13_CR110","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1021\/cb400080f","volume":"8","author":"MG Savelieff","year":"2013","unstructured":"Savelieff MG, Lee S, Liu Y et al (2013) Untangling amyloid-beta, tau, and metals in Alzheimer\u2019s disease. ACS Chem Biol 8(5):856\u2013865. https:\/\/doi.org\/10.1021\/cb400080f","journal-title":"ACS Chem Biol"},{"issue":"3","key":"13_CR111","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","volume":"23","author":"B Kim","year":"2012","unstructured":"Kim B, Feldman EL (2012) Insulin resistance in the nervous system. Trends Endocrinol Metab 23(3):133\u2013141. https:\/\/doi.org\/10.1016\/j.tem.2011.12.004","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"13_CR112","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","volume":"6","author":"C Sims-Robinson","year":"2010","unstructured":"Sims-Robinson C, Kim B, Rosko A et al (2010) How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 6(10):551\u2013559. https:\/\/doi.org\/10.1038\/nrneurol.2010.130","journal-title":"Nat Rev Neurol"},{"key":"13_CR113","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth BJ, Craft S (2017) Insulin resistance and Alzheimer\u2019s disease: bioenergetic linkages. Front Aging Neurosci 9:345. https:\/\/doi.org\/10.3389\/fnagi.2017.00345","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"13_CR114","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jnc.14037","volume":"143","author":"A Grimm","year":"2017","unstructured":"Grimm A, Eckert A (2017) Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 143(4):418\u2013431. https:\/\/doi.org\/10.1111\/jnc.14037","journal-title":"J Neurochem"},{"issue":"9","key":"13_CR115","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.3390\/ijms21093369","volume":"21","author":"H Park","year":"2020","unstructured":"Park H, Kang JH, Lee S (2020) Autophagy in neurodegenerative diseases: a hunter for aggregates. Int J Mol Sci 21(9):3369. https:\/\/doi.org\/10.3390\/ijms21093369","journal-title":"Int J Mol Sci"},{"issue":"4","key":"13_CR116","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/jad-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Reddy PH (2017) Therapeutics of neurotransmitters in Alzheimer\u2019s disease. J Alzheimers Dis 57(4):1049\u20131069. https:\/\/doi.org\/10.3233\/jad-161118","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"13_CR117","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"9","key":"13_CR118","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/jci90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT (2017) Microglia in Alzheimer\u2019s disease. J Clin Invest 127(9):3240\u20133249. https:\/\/doi.org\/10.1172\/jci90606","journal-title":"J Clin Invest"},{"key":"13_CR119","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/105828","volume":"2015","author":"G Verdile","year":"2015","unstructured":"Verdile G, Keane KN, Cruzat VF et al (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer\u2019s disease. Mediat Inflamm 2015:105828. https:\/\/doi.org\/10.1155\/2015\/105828","journal-title":"Mediat Inflamm"},{"key":"13_CR120","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","volume":"11","author":"H Hampel","year":"2020","unstructured":"Hampel H, Caraci F, Cuello AC et al (2020) A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer\u2019s disease. Front Immunol 11:456. https:\/\/doi.org\/10.3389\/fimmu.2020.00456","journal-title":"Front Immunol"},{"issue":"7","key":"13_CR121","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276\u20131290.e1217. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"2","key":"13_CR122","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368(2):117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"issue":"1","key":"13_CR123","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N et al (2020) Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun 11(1):6129. https:\/\/doi.org\/10.1038\/s41467-020-19737-2","journal-title":"Nat Commun"},{"issue":"6","key":"13_CR124","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y et al (2020) Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron 105(6):975\u2013991.e977. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.015","journal-title":"Neuron"},{"issue":"9","key":"13_CR125","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo JB, Arnold M, Kastenm\u00fcller G et al (2017) Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map. Alzheimers Dement 13(9):965\u2013984. https:\/\/doi.org\/10.1016\/j.jalz.2017.01.020","journal-title":"Alzheimers Dement"},{"issue":"2","key":"13_CR126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF, O\u2019Riordan KJ, Sandhu K et al (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179\u2013194. https:\/\/doi.org\/10.1016\/s1474-4422(19)30356-4","journal-title":"Lancet Neurol"},{"key":"13_CR127","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal R, Neth BJ, Wang S et al (2019) Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine 47:529\u2013542. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.032","journal-title":"EBioMedicine"},{"key":"13_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102950","volume":"59","author":"R Nagpal","year":"2020","unstructured":"Nagpal R, Neth BJ, Wang S et al (2020) Gut mycobiome and its interaction with diet, gut bacteria and Alzheimer\u2019s disease markers in subjects with mild cognitive impairment: a pilot study. EBioMedicine 59:102950. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102950","journal-title":"EBioMedicine"},{"issue":"1","key":"13_CR129","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","volume":"46","author":"S Rayaprolu","year":"2021","unstructured":"Rayaprolu S, Higginbotham L, Bagchi P et al (2021) Systems-based proteomics to resolve the biology of Alzheimer\u2019s disease beyond amyloid and tau. Neuropsychopharmacology 46(1):98\u2013115. https:\/\/doi.org\/10.1038\/s41386-020-00840-3","journal-title":"Neuropsychopharmacology"},{"key":"13_CR130","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neubiorev.2018.11.007","volume":"96","author":"ZT Wang","year":"2019","unstructured":"Wang ZT, Tan CC, Tan L et al (2019) Systems biology and gene networks in Alzheimer\u2019s disease. Neurosci Biobehav Rev 96:31\u201344. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.11.007","journal-title":"Neurosci Biobehav Rev"},{"issue":"S1","key":"13_CR131","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.3233\/jad-179932","volume":"64","author":"H Hampel","year":"2018","unstructured":"Hampel H, Toschi N, Babiloni C et al (2018) Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology. J Alzheimers Dis 64(S1):S47\u2013S105. https:\/\/doi.org\/10.3233\/jad-179932","journal-title":"J Alzheimers Dis"},{"issue":"9996","key":"13_CR132","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"2","key":"13_CR133","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/s1474-4422(19)30287-x","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 19(2):170\u2013178. https:\/\/doi.org\/10.1016\/s1474-4422(19)30287-x","journal-title":"Lancet Neurol"},{"issue":"3","key":"13_CR134","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamaneurol.2017.4206","volume":"75","author":"KC Paul","year":"2018","unstructured":"Paul KC, Schulz J, Bronstein JM et al (2018) Association of polygenic risk score with cognitive decline and motor progression in Parkinson disease. JAMA Neurol 75(3):360\u2013366. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4206","journal-title":"JAMA Neurol"},{"issue":"6","key":"13_CR135","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","volume":"53","author":"G Liu","year":"2021","unstructured":"Liu G, Peng J, Liao Z et al (2021) Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson\u2019s disease. Nat Genet 53(6):787\u2013793. https:\/\/doi.org\/10.1038\/s41588-021-00847-6","journal-title":"Nat Genet"},{"issue":"S1","key":"13_CR136","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.3233\/jpd-179001","volume":"7","author":"H Braak","year":"2017","unstructured":"Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson\u2019s disease: separating the wheat from the chaff. J Parkinsons Dis 7(S1):S71\u2013S85. https:\/\/doi.org\/10.3233\/jpd-179001","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"13_CR137","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12974-019-1532-2","volume":"16","author":"PJ Hallett","year":"2019","unstructured":"Hallett PJ, Engelender S, Isacson O (2019) Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson\u2019s disease. J Neuroinflammation 16(1):153. https:\/\/doi.org\/10.1186\/s12974-019-1532-2","journal-title":"J Neuroinflammation"},{"issue":"2","key":"13_CR138","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.stemcr.2019.01.011","volume":"12","author":"M Chai","year":"2019","unstructured":"Chai M, Kohyama J (2019) Non-cell-autonomous neurotoxicity in Parkinson\u2019s disease mediated by astroglial \u03b1-synuclein. Stem Cell Rep 12(2):183\u2013185. https:\/\/doi.org\/10.1016\/j.stemcr.2019.01.011","journal-title":"Stem Cell Rep"},{"issue":"8","key":"13_CR139","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/mds.27099","volume":"32","author":"H Payami","year":"2017","unstructured":"Payami H (2017) The emerging science of precision medicine and pharmacogenomics for Parkinson\u2019s disease. Mov Disord 32(8):1139\u20131146. https:\/\/doi.org\/10.1002\/mds.27099","journal-title":"Mov Disord"},{"key":"13_CR140","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu I, Bennett SAL (2019) Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease. Front Neurosci 13:328. https:\/\/doi.org\/10.3389\/fnins.2019.00328","journal-title":"Front Neurosci"},{"key":"13_CR141","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnmol.2020.00080","volume":"13","author":"L Hu","year":"2020","unstructured":"Hu L, Dong MX, Huang YL et al (2020) Integrated metabolomics and proteomics analysis reveals plasma lipid metabolic disturbance in patients with Parkinson\u2019s disease. Front Mol Neurosci 13:80. https:\/\/doi.org\/10.3389\/fnmol.2020.00080","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"13_CR142","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1212\/wnl.0000000000003663","volume":"88","author":"PA LeWitt","year":"2017","unstructured":"LeWitt PA, Li J, Lu M et al (2017) Metabolomic biomarkers as strong correlates of Parkinson disease progression. Neurology 88(9):862\u2013869. https:\/\/doi.org\/10.1212\/wnl.0000000000003663","journal-title":"Neurology"},{"issue":"9","key":"13_CR143","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, Ito M, Ishida T et al (2020) Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov Disord 35(9):1626\u20131635. https:\/\/doi.org\/10.1002\/mds.28119","journal-title":"Mov Disord"},{"issue":"S1","key":"13_CR144","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.3233\/jpd-181465","volume":"8","author":"AJ Espay","year":"2018","unstructured":"Espay AJ, Lang AE (2018) Parkinson diseases in the 2020s and beyond: replacing clinico-pathologic convergence with systems biology divergence. J Parkinsons Dis 8(S1):S59\u2013S64. https:\/\/doi.org\/10.3233\/jpd-181465","journal-title":"J Parkinsons Dis"},{"issue":"454","key":"13_CR145","doi-asserted-by":"publisher","first-page":"eaam6003","DOI":"10.1126\/scitranslmed.aam6003","volume":"10","author":"AS Chen-Plotkin","year":"2018","unstructured":"Chen-Plotkin AS, Albin R, Alcalay R et al (2018) Finding useful biomarkers for Parkinson\u2019s disease. Sci Transl Med 10(454):eaam6003. https:\/\/doi.org\/10.1126\/scitranslmed.aam6003","journal-title":"Sci Transl Med"},{"issue":"1","key":"13_CR146","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00441-017-2734-5","volume":"373","author":"E Glaab","year":"2018","unstructured":"Glaab E (2018) Computational systems biology approaches for Parkinson\u2019s disease. Cell Tissue Res 373(1):91\u2013109. https:\/\/doi.org\/10.1007\/s00441-017-2734-5","journal-title":"Cell Tissue Res"},{"issue":"1","key":"13_CR147","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","volume":"14","author":"Y Shao","year":"2019","unstructured":"Shao Y, Le W (2019) Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease. Mol Neurodegener 14(1):3. https:\/\/doi.org\/10.1186\/s13024-018-0304-2","journal-title":"Mol Neurodegener"},{"issue":"6","key":"13_CR148","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/ede.0000000000000381","volume":"26","author":"A Al-Chalabi","year":"2015","unstructured":"Al-Chalabi A, Pearce N (2015) Commentary: mapping the human exposome: without it, how can we find environmental risk factors for ALS? Epidemiology 26(6):821\u2013823. https:\/\/doi.org\/10.1097\/ede.0000000000000381","journal-title":"Epidemiology"},{"key":"13_CR149","volume-title":"Atlas of neuromuscular diseases: a practical guideline","author":"MG Savelieff","year":"2021","unstructured":"Savelieff MG, Stino AM (2021) New neuromuscular therapies. In: Feldman EL, Russell J, L\u00f6scher WN, Grisold W, Meng S (eds) Atlas of neuromuscular diseases: a practical guideline, 3rd edn. Springer, Berlin","edition":"3"},{"key":"13_CR150","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.1038\/ncomms12408","volume":"7","author":"KC Arthur","year":"2016","unstructured":"Arthur KC, Calvo A, Price TR et al (2016) Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun 7:12408\u201312408. https:\/\/doi.org\/10.1038\/ncomms12408","journal-title":"Nat Commun"},{"issue":"1","key":"13_CR151","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.molmed.2015.11.001","volume":"22","author":"D Caballero-Hernandez","year":"2016","unstructured":"Caballero-Hernandez D, Toscano MG, Cejudo-Guillen M et al (2016) The \u2018omics\u2019 of amyotrophic lateral sclerosis. Trends Mol Med 22(1):53\u201367. https:\/\/doi.org\/10.1016\/j.molmed.2015.11.001","journal-title":"Trends Mol Med"},{"issue":"1","key":"13_CR152","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13311-016-0503-x","volume":"14","author":"LT Vu","year":"2017","unstructured":"Vu LT, Bowser R (2017) Fluid-based biomarkers for amyotrophic lateral sclerosis. Neurotherapeutics 14(1):119\u2013134. https:\/\/doi.org\/10.1007\/s13311-016-0503-x","journal-title":"Neurotherapeutics"},{"issue":"12","key":"13_CR153","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.3390\/ijms22126352","volume":"22","author":"E Obrador","year":"2021","unstructured":"Obrador E, Salvador-Palmer R, L\u00f3pez-Blanch R et al (2021) The link between oxidative stress, redox status, bioenergetics and mitochondria in the pathophysiology of ALS. Int J Mol Sci 22(12):6352. https:\/\/doi.org\/10.3390\/ijms22126352","journal-title":"Int J Mol Sci"},{"issue":"11","key":"13_CR154","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3390\/ijms20112818","volume":"20","author":"MAJ van den Bos","year":"2019","unstructured":"van den Bos MAJ, Geevasinga N, Higashihara M et al (2019) Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques. Int J Mol Sci 20(11):2818. https:\/\/doi.org\/10.3390\/ijms20112818","journal-title":"Int J Mol Sci"},{"issue":"9","key":"13_CR155","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1073\/pnas.1112427109","volume":"109","author":"Y Kawahara","year":"2012","unstructured":"Kawahara Y, Mieda-Sato A (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A 109(9):3347\u20133352. https:\/\/doi.org\/10.1073\/pnas.1112427109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"13_CR156","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s12035-013-8564-x","volume":"48","author":"V Di Carlo","year":"2013","unstructured":"Di Carlo V, Grossi E, Laneve P et al (2013) TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation. Mol Neurobiol 48(3):952\u2013963. https:\/\/doi.org\/10.1007\/s12035-013-8564-x","journal-title":"Mol Neurobiol"},{"issue":"3","key":"13_CR157","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1007\/s12035-017-0537-z","volume":"55","author":"P Rinchetti","year":"2018","unstructured":"Rinchetti P, Rizzuti M, Faravelli I et al (2018) MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis. Mol Neurobiol 55(3):2617\u20132630. https:\/\/doi.org\/10.1007\/s12035-017-0537-z","journal-title":"Mol Neurobiol"},{"issue":"12","key":"13_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052672","volume":"7","author":"C Figueroa-Romero","year":"2012","unstructured":"Figueroa-Romero C, Hur J, Bender DE et al (2012) Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS One 7(12):e52672. https:\/\/doi.org\/10.1371\/journal.pone.0052672","journal-title":"PLoS One"},{"issue":"5\u20136","key":"13_CR159","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/21678421.2019.1587634","volume":"20","author":"M Benatar","year":"2019","unstructured":"Benatar M, Turner MR, Wuu J (2019) Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 20(5\u20136):303\u2013309. https:\/\/doi.org\/10.1080\/21678421.2019.1587634","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"18","key":"13_CR160","doi-asserted-by":"publisher","first-page":"e2089","DOI":"10.1212\/wnl.0000000000007401","volume":"92","author":"K Bjornevik","year":"2019","unstructured":"Bjornevik K, Zhang Z, O\u2019Reilly \u00c9J et al (2019) Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 92(18):e2089\u2013e2100. https:\/\/doi.org\/10.1212\/wnl.0000000000007401","journal-title":"Neurology"},{"issue":"6","key":"13_CR161","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/acn3.51006","volume":"7","author":"C Figueroa-Romero","year":"2020","unstructured":"Figueroa-Romero C, Mikhail KA, Gennings C et al (2020) Early life metal dysregulation in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 7(6):872\u2013882. https:\/\/doi.org\/10.1002\/acn3.51006","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"13_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007773","volume":"16","author":"P Curtin","year":"2020","unstructured":"Curtin P, Austin C, Curtin A et al (2020) Dysregulated biodynamics in metabolic attractor systems precede the emergence of amyotrophic lateral sclerosis. PLoS Comput Biol 16(4):e1007773. https:\/\/doi.org\/10.1371\/journal.pcbi.1007773","journal-title":"PLoS Comput Biol"},{"issue":"7770","key":"13_CR163","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, Bashiardes S, Shapiro H et al (2019) Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572(7770):474\u2013480. https:\/\/doi.org\/10.1038\/s41586-019-1443-5","journal-title":"Nature"},{"issue":"2","key":"13_CR164","doi-asserted-by":"publisher","first-page":"dmm041947","DOI":"10.1242\/dmm.041947","volume":"13","author":"C Figueroa-Romero","year":"2019","unstructured":"Figueroa-Romero C, Guo K, Murdock BJ et al (2019) Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Model Mech 13(2):dmm041947. https:\/\/doi.org\/10.1242\/dmm.041947","journal-title":"Dis Model Mech"},{"issue":"1","key":"13_CR165","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s13063-019-3664-1","volume":"20","author":"JJH Park","year":"2019","unstructured":"Park JJH, Siden E, Zoratti MJ et al (2019) Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Trials 20(1):572. https:\/\/doi.org\/10.1186\/s13063-019-3664-1","journal-title":"Trials"},{"issue":"1","key":"13_CR166","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","volume":"13","author":"RJ Bateman","year":"2017","unstructured":"Bateman RJ, Benzinger TL, Berry S et al (2017) The DIAN-TU next generation Alzheimer\u2019s prevention trial: adaptive design and disease progression model. Alzheimers Dement 13(1):8\u201319. https:\/\/doi.org\/10.1016\/j.jalz.2016.07.005","journal-title":"Alzheimers Dement"},{"issue":"12","key":"13_CR167","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021017","volume":"8","author":"A Solomon","year":"2019","unstructured":"Solomon A, Kivipelto M, Molinuevo JL et al (2019) European Prevention of Alzheimer\u2019s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open 8(12):e021017. https:\/\/doi.org\/10.1136\/bmjopen-2017-021017","journal-title":"BMJ Open"}],"container-title":["Methods in Molecular Biology","Systems Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2265-0_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T16:13:11Z","timestamp":1650384791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2265-0_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071622643","9781071622650"],"references-count":167,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2265-0_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"19 April 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}